These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14560611)

  • 1. [Guidelines for anti-platelet and anti-coagulation therapies--based on evidences in the United States and Japan].
    Hori M; Sato H
    Nihon Naika Gakkai Zasshi; 2003 Sep; 92(9):1733-40. PubMed ID: 14560611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 3. The combination of anticoagulant and anti-platelet therapy in patients with atrial fibrillation: a comment on the recent ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation.
    Rubboli A; Di Pasquale G
    Eur Heart J; 2006 Dec; 27(23):2908-9; author reply 2909-10. PubMed ID: 17074773
    [No Abstract]   [Full Text] [Related]  

  • 4. Putting a stop to thrombi.
    Palatnik A
    Nursing; 2007; 37 Suppl Cardiac():2-6. PubMed ID: 18075484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T
    Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin for atrial fibrillation.
    Douglas M; Strelnick A
    J Fam Pract; 2000 Jan; 49(1):7-8. PubMed ID: 10678329
    [No Abstract]   [Full Text] [Related]  

  • 7. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical guidelines for inhibitors of hemostasis and locoregional neuraxial anesthesia. Spanish Society of Anesthesiology-Resuscitation and Pain Therapy, Division of Hemostasis, Transfusion Medicine, and Perioperative Fluid Therapy].
    Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor, Sección de Hemostasia, Medicina Transfusional y Fluidoterapia Perioperatoria
    Rev Esp Anestesiol Reanim; 2005; 52(7):413-20. PubMed ID: 16200921
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
    Diner BM
    Ann Emerg Med; 2003 Jan; 41(1):141-3. PubMed ID: 12514695
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk?
    Marín F; Bonacasa B; Valdés M
    Thromb Haemost; 2010 Jan; 103(1):11-2. PubMed ID: 20062940
    [No Abstract]   [Full Text] [Related]  

  • 11. New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation.
    Kuzniatsova N; Lip GY
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1643-7. PubMed ID: 21108546
    [No Abstract]   [Full Text] [Related]  

  • 12. The CARI guidelines. Pharmacological approaches to preventing vascular access failure.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119
    [No Abstract]   [Full Text] [Related]  

  • 13. [Old patient with atrial fibrillation: do you too hesitate to use anticoagulants?].
    MMW Fortschr Med; 2006 Sep; 148(38):14. PubMed ID: 17036954
    [No Abstract]   [Full Text] [Related]  

  • 14. Review: anticoagulants may be better than antiplatelet agents for nonfatal stroke but not other vascular or fatal events in nonrheumatic AF.
    Ebrahim S; Taylor F
    ACP J Club; 2001; 135(2):A17. PubMed ID: 11571899
    [No Abstract]   [Full Text] [Related]  

  • 15. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation--the J-RHYTHM Registry study design.
    Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
    J Cardiol; 2011 Jan; 57(1):95-9. PubMed ID: 20934857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation.
    Marchant BG; Timmis AD
    Br J Hosp Med; 1993 Feb 3-16; 49(3):186-90. PubMed ID: 8439785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation therapy in paroxysmal atrial fibrillation].
    Risøe C; Gjesdal K
    Tidsskr Nor Laegeforen; 2004 Apr; 124(7):950-2. PubMed ID: 15060644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Apostolakis S; Shantsila E; Lip GY; Lane DA
    Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.